MLM Companies
USANA Health Sciences Review 2026
Publicly traded nutrition MLM with declining revenue trend
Last updated: January 15, 2026
What is USANA Health Sciences?
Nutritional supplements, diet and energy products, and personal care products sold through a network of Associates. Publicly traded on NYSE (USNA). Revenue declined from $921M (2023) to $855M (2024).
Pros
- 32 years in business — public company (NYSE: USNA)
- Quality supplements with strong manufacturing standards
- No required autoship — flexible purchase structure
- Weekly commission payments
Cons
- Low per-customer residual (~$9/mo)
- Monthly point requirements for commissions
- Complex binary compensation plan
- Revenue declining ($921M → $855M, 2023-24)
Rating Breakdown
Residual Income
2.2
Potential for ongoing passive income
Simplicity
2.0
Easy to understand and execute
Transparency
2.0
Clear about costs, requirements, and income
Community & Support
3.0
Quality of training and community
Value for Money
4.0
Worth the investment
Overall Rating
2.2
Frequently Asked Questions About USANA Health Sciences
Is USANA a good MLM?
USANA is publicly traded (NYSE: USNA), providing transparency unusual in MLMs. Products are manufactured to pharmaceutical-grade standards. The binary compensation structure requires building balanced teams for meaningful income.
Is USANA publicly traded?
Yes. USANA Health Sciences (USNA) trades on the NYSE. Full-year 2024 results showed net sales of $855 million and net earnings of $42 million — down from $921M and $63.8M respectively in 2023.
What are USANA's best products?
USANA's CellSentials (multivitamin/antioxidant), BiOmega (fish oil), and Active Nutrition products are among their most popular. Products are manufactured to pharmaceutical-grade standards in their own facility.
Compare USANA Health Sciences with Alternatives
See how USANA Health Sciences stacks up against the competition
Compare with Home Business Academy